Finance

Lists
Outlook: 50.0% bullish·15.4% bearish
Go to analysis
SYK:NYSE
Stryker Corp
294,66 USD
+0,49%
(+1,43) 1D
295,00 USD
+0,12% (+0,34)
After hours
Closed: 16-окт., 16:02:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYK...
Open
295,89 USD
High
299,67 USD
Low
293,75 USD
Mkt. cap
113,02 млд
Avg. vol.
2,93 млн
Volume
3,38 млн
Dividend
1,19%
Quarterly dividend
0,88 USD
Ex-dividend date
2026-ж., 30-сен.
P/E ratio
30,53
52-wk high
392,55 USD
52-wk low
267,00 USD
EPS
9,65 USD
Beta
0,77
Shares outstanding
383,57 млн
No. of employees
56 миң
Open
295,89 USD
High
299,67 USD
Low
293,75 USD
Mkt. cap
113,02 млд
Avg. vol.
2,93 млн
Volume
3,38 млн
Dividend
1,19%
Quarterly dividend
0,88 USD
Ex-dividend date
2026-ж., 30-сен.
P/E ratio
30,53
52-wk high
392,55 USD
52-wk low
267,00 USD
EPS
9,65 USD
Beta
0,77
Shares outstanding
383,57 млн
No. of employees
56 миң
News stories
From web sources and news partners
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp
CEOKevin A. Lobo
Employees56 миң
Founded1941
HeadquartersКаламазу, Мичиган, Америка Кошмо Штаттары
SectorMedical device
Analyst ratings
Based on 20 analysts giving stock ratings to SYK in the past 3 months
Strong buy
Buy
18
Hold
2
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for SYK in the last 3 months.
Highest
Current 294,66 USD
420,00 USD (+42,54%)
Average
364,72 USD (+23,78%)
Lowest
298,00 USD (+1,13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vik Chopra
BMO Capital
Buy
Maintained
317,00 USD
+7,6%
10/12/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
385,00 USD
+30,7%
10/13/2026
Christopher Pasquale
Barclays
Buy
Maintained
375,00 USD
+27,3%
10/13/2026
Ryan Zimmerman
BTIG
Buy
Maintained
316,00 USD
+7,2%
10/12/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
353,00 USD
+19,8%
10/12/2026
Joanne Wuensch
Citi
Buy
Maintained
-
-
10/07/2026
Travis Steed
Bank of America Securities
Buy
Maintained
380,00 USD
+29%
10/06/2026
Matt Miksic
Barclays
Buy
Maintained
375,00 USD
+27,3%
10/07/2026
Richard Newitter
Truist Financial
Hold
Maintained
310,00 USD
+5,2%
10/06/2026
Michael Matson
Needham
Buy
Maintained
418,00 USD
+41,9%
10/06/2026
Kendall Au
RBC Capital
Buy
Maintained
420,00 USD
+42,5%
10/01/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
330,00 USD
+12%
09/30/2026
Matthew Taylor
Jefferies
Buy
Maintained
405,00 USD
+37,4%
09/22/2026
Mathew Blackman
TD Cowen
Hold
Reiterated
298,00 USD
+1,1%
09/22/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
385,00 USD
+30,7%
09/18/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
420,00 USD
+42,5%
09/16/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
348,00 USD
+18,1%
09/16/2026
Steven Lichtman
William Blair
Buy
Reiterated
-
-
09/09/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
350,00 USD
+18,8%
08/04/2026
David Turkaly
Citizens JMP
Buy
Maintained
400,00 USD
+35,7%
08/03/2026
Jayson Bedford
Raymond James
Buy
Maintained
370,00 USD
+25,6%
07/31/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
390,00 USD
+32,4%
07/31/2026
Patrick Wood
UBS
Buy
Upgraded
400,00 USD
+35,7%
07/28/2026
David Toung
Argus Research
Buy
Reiterated
370,00 USD
+25,6%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
418,00 USD
+41,9%
07/08/2026
Unknown Analyst
BMO Capital
Buy
Initiated
369,00 USD
+25,2%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
350,00 USD
+18,8%
07/06/2026
David Roman
Goldman Sachs
Hold
Maintained
361,00 USD
+22,5%
05/01/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
385,00 USD
+30,7%
05/01/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
315,00 USD
+6,9%
05/01/2026
Lee Hambright
Bernstein
Buy
Maintained
410,00 USD
+39,1%
05/01/2026
Nico Chen
DBS
Buy
Maintained
450,00 USD
+52,7%
03/18/2026
Danielle Antalffy
UBS
Hold
Reiterated
380,00 USD
+29%
03/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
465,00 USD
+57,8%
03/05/2026
Next call 12 күндөн кийин
29-окт., бейш., 22:30
Fiscal period
Q3 2026
- / 3,53 USD
Revenue / Est. (USD)
- / 6,62 млд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,06 млд
7,17 млд
6,02 млд
6,59 млд
Cost of goods sold
2,12 млд
2,49 млд
2,19 млд
2,08 млд
Cost of revenue
2,12 млд
2,49 млд
2,19 млд
2,08 млд
Research and development expenses
409,00 млн
388,00 млн
409,00 млн
429,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,99 млд
2,15 млд
2,16 млд
2,13 млд
Operating expense
2,58 млд
2,72 млд
2,75 млд
2,73 млд
Total operating expenses
4,71 млд
5,22 млд
4,95 млд
4,81 млд
Operating income
1,35 млд
1,95 млд
1,07 млд
1,78 млд
Other non operating income
-138,00 млн
420,00 млн
19,00 млн
1,00 млн
EBT including unusual items
1,03 млд
1,70 млд
850,00 млн
1,56 млд
EBT excluding unusual items
1,25 млд
1,81 млд
987,00 млн
1,68 млд
Income tax expense
170,00 млн
856,00 млн
105,00 млн
288,00 млн
Effective tax rate
16,52%
50,21%
12,35%
18,41%
Other operating expenses
-
-
-
-
Net income
859,00 млн
849,00 млн
745,00 млн
1,28 млд
Net profit margin
14,18%
11,84%
12,38%
19,37%
Earnings per share
3,19
4,47
2,60
3,69
Interest and investment income
28,00 млн
31,00 млн
34,00 млн
26,00 млн
Interest expense
-
-607,00 млн
-148,00 млн
-141,00 млн
Net interest expenses
28,00 млн
-576,00 млн
-114,00 млн
-115,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 млд
2,27 млд
1,37 млд
2,08 млд
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору